High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cytokine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cyto.2011.10.020PMID 22136974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An artificial neural network improves the non-invasive diagnosis of significant fibrosis in HIV/HCV coinfected patients.

  2011cited by this paper
• Chemokine antagonism in chronic hepatitis C virus infection.

  2011cited by this paper
• Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.

  2011influential reference
• Plasma interferon-gamma-inducible protein-10 can predict virologic response to hepatitis C virus therapy in HIV/HCV-coinfected patients with HCV genotype 1.

  2010cited by this paper
• CD81 expression in peripheral blood lymphocytes before and after treatment with interferon and ribavirin in HIV/HCV coinfected patients

  2010cited by this paper
• Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.

  2010cited by this paper
• Systemic and intrahepatic interferon‐gamma‐inducible protein 10 kDa predicts the first‐phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

  2010cited by this paper
• Association among Fas expression in leucocytes, serum Fas and Fas‐ligand concentrations and hepatic inflammation and fibrosis in chronic hepatitis C

  2010cited by this paper
• Insulin Resistance Impairs Response to Interferon Plus Ribavirin in Patients Coinfected With HIV and Hepatitis C Virus

  2010cited by this paper
• Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.

  2009cited by this paper
• Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data

  2009cited by this paper
• Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.

  2009cited by this paper
• Chemokines in the immunopathogenesis of hepatitis C infection

  2009cited by this paper
• IP-10 Correlates with Hepatitis C Viral Load, Hepatic Inflammation and Fibrosis and Predicts Hepatitis C Virus Relapse or Non-Response in HIV–HCV Coinfection

  2008cited by this paper
• The Prevalence and Risk Factors for Abnormal Liver Enzymes in HIV-Positive Patients without Hepatitis B or C Coinfections

  2008influential reference
• Interferon signaling and treatment outcome in chronic hepatitis C

  2008cited by this paper
• Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART

  2008cited by this paper
• Interferon γ-Inducible Protein 10: A Predictive Marker of Successful Treatment Response in Hepatitis C Virus/HIV-Coinfected Patients

  2007cited by this paper
• Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV.

  2007cited by this paper
• Interferon gamma-inducible protein 10: a predictive marker of successful treatment response in hepatitis C virus/HIV-coinfected patients.

  2007cited by this paper
• Identification of liver fibrosis in HIV/HCV‐coinfected patients using a simple predictive model based on routine laboratory data

  2007cited by this paper
• Proinflammatory Cytokines, Insulin Resistance, and Insulin Secretion in Chronic Hepatitis C patients

  2006cited by this paper
• Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.

  2006cited by this paper
• Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease.

  2005cited by this paper
• Association of pretreatment serum interferon γ inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C

  2005cited by this paper
• Expression of the chemokine IP‐10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation

  2003cited by this paper
• A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C

  2003cited by this paper
• Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

  2002cited by this paper
• DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study.

  2001cited by this paper
• Interferons and interferon (IFN)‐inducible protein 10 during highly active anti‐retroviral therapy (HAART)—possible immunosuppressive role of IFN‐α in HIV infection

  2000influential reference
• CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system.

  1998cited by this paper

• Circulating macrophage inflammatory protein-1 β /IL-12p40 ratio predicts sofosbuvir-based treatment outcome in HCV- genotype 4 patients

  2021cites this paper
• Recurrent circadian fasting (RCF) improves blood pressure, biomarkers of cardiometabolic risk and regulates inflammation in men

  2019cites this paper
• Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients

  2018cites this paper
• Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality

  2018cites this paper
• Immune Activation, Proinflammatory Cytokines, and Conventional Risks for Cardiovascular Disease in HIV Patients: A Case-Control Study in Bahia, Brazil

  2018cites this paper
• Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail

  2018cites this paper
• Elevated serum interferon γ-inducible protein-10 in women with polycystic ovary syndrome

  2017cites this paper
• Genetic Polymorphisms Associated with Liver Disease Progression in HIV/HCV-Coinfected Patients.

  2017cites this paper
• CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study

  2017cites this paper
• Interferon-γ-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features & sustained virological response

  2017cites this paper
• Prevention of type 2 diabetes in people living with HIV : understanding risk factors, and investigating the effectiveness and acceptability of a lifestyle intervention

  2016cites this paper
• Chemokine (C‐X‐C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt

  2016cites this paper
• New Biomarkers for Response to Treatment of HCV Infected Patients Based on IP-10 and IL 28B Polymorphism Analysis

  2016cites this paper
• Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease

  2015cites this paper
• CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.

  2015cites this paper
• Single Nucleotide Polymorphisms of CXCL9-11 Chemokines Are Associated With Liver Fibrosis in HIV/HCV-Coinfected Patients

  2015cites this paper
• CXCR3 ligands in disease and therapy.

  2015cites this paper
• Understanding the Mechanisms of Fibrogenesis in HIV/HCV-Coinfected Patients: Implications for Clinical Practice.

  2015cites this paper
• Inflammation chronique et hyperactivation du système immunitaire chez les patients HIV controllers : liens avec le contrôle antiviral et la mise en jeu de la voie des interférons

  2014cites this paper
• Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection

  2014cites this paper
• The role of chemokines in acute and chronic hepatitis C infection

  2013cites this paper
• Association of Interferon-gamma Induced Protein 10 Promoter Polymorphisms with the Disease Progression of Hepatitis B Virus Infection in Chinese Han Population

  2013cites this paper
• CXC chemokine IP-10: a key actor in liver disease?

  2013cites this paper
• Predictors of Chronic Hepatitis C Evolution in HIV Co-Infected Patients From Romania

  2013cites this paper
• Crosstalk between HIV and hepatitis C virus during co-infection

  2012cites this paper